Nanotechnology: Toxicologic PathologyHUBBS, Ann F; SARGENT, Linda M; BATTELLI, Lori A et al.Toxicologic pathology. 2013, Vol 41, Num 2, pp 395-409, issn 0192-6233, 15 p.Article

Use of Animal Models of Human Disease for Nonclinical Safety Assessment of Novel PharmaceuticalsMORGAN, Sherry J; ELANGBAM, Chandikumar S; BERENS, Shawn et al.Toxicologic pathology. 2013, Vol 41, Num 3, pp 508-518, issn 0192-6233, 11 p.Article

Safety Assessment Considerations and Strategies for Targeted Small Molecule Cancer Therapeutics in Drug DiscoveryWESTHOUSE, Richard A.Toxicologic pathology. 2010, Vol 38, Num 1, pp 165-168, issn 0192-6233, 4 p.Article

Toxicologic Pathology in a Multicultural World—IndiaSCHULTZE, A. Eric; REDDY, Vijayapal R; DONNELLY, Kevin B et al.Toxicologic pathology. 2011, Vol 39, Num 6, pp 1003-1009, issn 0192-6233, 7 p.Article

Predictive Toxicology Approaches for Small Molecule Oncology DrugsMAZIASZ, T; KADAMBI, V. J; SILVERMAN, L et al.Toxicologic pathology. 2010, Vol 38, Num 1, pp 148-164, issn 0192-6233, 17 p.Article

Quantitative Histopathological Assessment of Retardation of Islets of Langerhans Degeneration in Rosiglitazone-dosed Obese ZDF Rats Using Combined Insulin and Collagens (I and III) Immunohistochemistry with Automated Image Analysis and Statistical ModelingJONES, Huw B; BIGLEY, Alison L; PEMBERTON, John et al.Toxicologic pathology. 2013, Vol 41, Num 3, pp 425-444, issn 0192-6233, 20 p.Article

The Role of Protease Inhibitors in the Pathogenesis of HIV-Associated Lipodystrophy : Cellular Mechanisms and Clinical ImplicationsFLINT, Oliver P; NOOR, Mustafa A; HRUZ, Paul W et al.Toxicologic pathology. 2009, Vol 37, Num 1, pp 65-77, issn 0192-6233, 13 p.Conference Paper